expert-advice
Showing 25-34 of 34 articles
Fauci expects to retire by end of Biden's current term
Dr. Anthony Fauci, the government's top infectious disease expert, said Monday he plans to retire by the end of President Joe Biden's term in January 2025. Fauc
Experts divided on whether taking Juul off market would dent teen vaping
Experts are divided over whether efforts to keep Juul products off the market will put a dent in the youth vaping epidemic. The Food and Drug Administration mad
Fauci: Take new subvariant seriously, but don’t ‘let it disrupt our lives’
Anthony Fauci, the government’s top infectious disease expert, said Tuesday that a new omicron subvariant on the rise is something to take seriously but should
These 31 Affordable Beauty Products Are Going Absolutely Viral on Amazon
The vast world of beauty products can be overwhelming. Whether you seek advice from experts on Instagram, influencers on TikTok, or even our own editors, determ
Mobility and Automation in Advanced Wound Care Improve Patient Outcomes
Through the height of the COVID-19 pandemic, experts say that surgical and chronic wound care became a challenge, as many patients recovered at home and receive
This Dermatologist-Loved Retinol Is Finally on Sale
From busting blemishes to ironing out fine lines, retinol is a star player in the world of multitasking skin-care ingredients. Naturally, experts are quick to r
Experts Say We'll See These Hair Color Trends Everywhere in 2022
Your natural color, but better Experts say 2022 will be a great time to focus on embracing your natural color but enhancing it a bit. Celebrity colorist Tania W
First probable monkeypox case reported in Iowa
Iowa health officials reported the state’s first probable case of monkeypox on Friday as infectious disease experts warn the country is at risk of losing contro
FDA panel votes to greenlight updating COVID vaccines for omicron
An expert advisory vaccine panel for the Food and Drug Administration (FDA) on Tuesday voted in favor of recommending updated COVID-19 vaccines specifically des
Pharma under the microscope as FTC considers new ways to review acquisitions
Drugmaker acquisitions of all sizes could receive closer scrutiny in the future if the Federal Trade Commission follows the advice of experts who spoke at a two